389 related articles for article (PubMed ID: 20010854)
1. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Li T; Su Y; Mei Y; Leng Q; Leng B; Liu Z; Stass SA; Jiang F
Lab Invest; 2010 Feb; 90(2):234-44. PubMed ID: 20010854
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
[TBL] [Abstract][Full Text] [Related]
3. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
4. Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Kalantari E; Saadi FH; Asgari M; Shariftabrizi A; Roudi R; Madjd Z
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):592-598. PubMed ID: 26894647
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
8. ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Yang L; Ren Y; Yu X; Qian F; Bian BS; Xiao HL; Wang WG; Xu SL; Yang J; Cui W; Liu Q; Wang Z; Guo W; Xiong G; Yang K; Qian C; Zhang X; Zhang P; Cui YH; Bian XW
Mod Pathol; 2014 May; 27(5):775-83. PubMed ID: 24201124
[TBL] [Abstract][Full Text] [Related]
9. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
10. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
11. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Med Oncol; 2013; 30(2):574. PubMed ID: 23585015
[TBL] [Abstract][Full Text] [Related]
13. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Khoury T; Ademuyiwa FO; Chandrasekhar R; Jabbour M; Deleo A; Ferrone S; Wang Y; Wang X
Mod Pathol; 2012 Mar; 25(3):388-97. PubMed ID: 22080062
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
Hou W; He W; Li Y; Ma R; Wang Z; Zhu X; Fu Q; Wen Y; Li H; Wen W
Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):171-9. PubMed ID: 23625387
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
[TBL] [Abstract][Full Text] [Related]
19. ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Adam SA; Schnell O; Pöschl J; Eigenbrod S; Kretzschmar HA; Tonn JC; Schüller U
Brain Pathol; 2012 Nov; 22(6):788-97. PubMed ID: 22417385
[TBL] [Abstract][Full Text] [Related]
20. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
